ePROMs + Information Hub for Chronic Kidney Failure

Recruiting in Palo Alto (17 mi)

+2 other locations

Overseen byIstvan Mucsi

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University Health Network, Toronto

No Placebo Group

Trial Summary

What is the purpose of this trial?This is a parallel arm, pilot study used to examine the feasibility of electronic patient reported outcome measures (ePROMs) for symptom assessment and monitoring as well as a linked self-management support and decision support information hub (https://symptomcare.org) to facilitate symptom management for patients on maintenance hemodialysis. Two dialysis centers will be included in the study, with one center receiving SUPPORT-Dialysis (intervention arm) and the other receiving standard care (control arm).

Eligibility Criteria

This trial is for patients who have been on maintenance hemodialysis for over 3 months due to kidney disease. It's not suitable for those with severe acute illnesses, non-English speakers, a life expectancy under 6 months, dementia, or an inability to consent.

Inclusion Criteria

I have been on hemodialysis for over 3 months.

Exclusion Criteria

Patients with severe acute illness or condition that hampers questionnaire completion assessed by clinical team

Unable to understand English - as assessed by clinical team

Your doctor believes you have less than 6 months to live.

+2 more

Participant Groups

The study tests SUPPORT-DIALYSIS with access to a symptom management website against standard care without this tool. Patients at two dialysis centers will be randomly assigned to either use the ePROMs and information hub or receive the usual treatment.

2Treatment groups

Experimental Treatment

Group I: SUPPORT-DIALYSIS with Access to Output Report and Information HubExperimental Treatment1 Intervention

Feasibility of SUPPORT-Dialysis at Toronto General Hospital

Group II: SUPPORT-DIALYSIS OnlyExperimental Treatment1 Intervention

Usual Treatment at Humber River Hospital